title: Constitutive receptor-independent low density lipoprotein uptake and cholesterol accumulation by macrophages differentiated from human monocytes with macrophage-colony-stimulating factor (M-CSF).
abstract: Recently, we have shown that macrophage uptake of low density lipoprotein (LDL) and cholesterol accumulation can occur by nonreceptor mediated fluid-phase macropinocytosis when macrophages are differentiated from human monocytes in human serum and the macrophages are activated by stimulation of protein kinase C (Kruth, H. S., Jones, N. L., Huang, W., Zhao, B., Ishii, I., Chang, J., Combs, C. A., Malide, D., and Zhang, W. Y. (2005) J. Biol. Chem. 280, 2352-2360). Differentiation of human monocytes in human serum produces a distinct macrophage phenotype. In this study, we examined the effect on LDL uptake of an alternative macrophage differentiation phenotype. Differentiation of macrophages from human monocytes in fetal bovine serum with macrophage-colony-stimulating factor (M-CSF) produced a macrophage phenotype demonstrating constitutive fluid-phase uptake of native LDL leading to macrophage cholesterol accumulation. Fluid-phase endocytosis of LDL by M-CSF human macrophages showed non-saturable uptake of LDL that did not down-regulate over 48 h. LDL uptake was mediated by continuous actin-dependent macropinocytosis of LDL by these M-CSF-differentiated macrophages. M-CSF is a cytokine present within atherosclerotic lesions. Thus, macropinocytosis of LDL by macrophages differentiated from monocytes under the influence of M-CSF is a plausible mechanism to account for macrophage foam cell formation in atherosclerotic lesions. This mechanism of macrophage foam cell formation does not depend on LDL modification or macrophage receptors.
authors.affiliation: Section of Experimental Atherosclerosis, NHLBI, National Institutes of Health, Bethesda, Maryland 20892-1422, USA.
authors.forename: Bin
authors.initials: B
authors.lastname: Zhao
authors.forename: Yifu
authors.initials: Y
authors.lastname: Li
authors.forename: Chiara
authors.initials: C
authors.lastname: Buono
authors.forename: Stephen W
authors.initials: SW
authors.lastname: Waldo
authors.forename: Nancy L
authors.initials: NL
authors.lastname: Jones
authors.forename: Masahiro
authors.initials: M
authors.lastname: Mori
authors.forename: Howard S
authors.initials: HS
authors.lastname: Kruth
mesh_terms: D002454:Cell Differentiation / Q000187:drug effects*; D002784:Cholesterol / Q000378:metabolism*; D000090702:Constitutive Androstane Receptor; D006801:Humans; D016753:Interleukin-10 / Q000494:pharmacology; D008077:Lipoproteins, LDL / Q000378:metabolism*; D016173:Macrophage Colony-Stimulating Factor / Q000494:pharmacology*; D008264:Macrophages / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D009000:Monocytes; D018160:Receptors, Cytoplasmic and Nuclear / Q000378:metabolism*; D014157:Transcription Factors / Q000378:metabolism*
chemical_list: D000090702:Constitutive Androstane Receptor; D008077:Lipoproteins, LDL; D018160:Receptors, Cytoplasmic and Nuclear; D014157:Transcription Factors; D016753:Interleukin-10; D016173:Macrophage Colony-Stimulating Factor; D002784:Cholesterol